Landfar Bio-medicine Co., Ltd (SHE:000504)
8.24
+0.33 (4.17%)
Jun 23, 2026, 3:04 PM CST
Landfar Bio-medicine Market Cap
Landfar Bio-medicine has a market cap or net worth of 2.61 billion as of June 23, 2026. Its market cap has increased by 12.52% in one year.
Market Cap
2.61B
Enterprise Value
2.75B
Revenue
512.79M
Ranking
n/a
PE Ratio
60.08
Stock Price
8.24
Market Cap Chart
Since October 24, 2002, Landfar Bio-medicine's market cap has decreased from 2.85B to 2.61B, a decrease of -8.52%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 2.61B | -11.62% |
| Dec 31, 2025 | 2.95B | 7.19% |
| Dec 31, 2024 | 2.76B | -23.75% |
| Dec 29, 2023 | 3.61B | -0.34% |
| Dec 30, 2022 | 3.63B | -37.42% |
| Dec 31, 2021 | 5.80B | 51.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Goto Biopharm | 3.07B |
| Guanhao Biotech | 2.93B |
| Zhejiang Shouxiangu Pharmaceutical | 2.89B |
| Guangdong VTR Bio-Tech | 2.83B |
| Beijing Kawin Technology Share-Holding | 2.71B |
| Yantai Zhenghai Biotechnology | 2.66B |
| Novoprotein Scientific | 2.51B |
| Shenzhen Bioeasy Biotechnology | 2.48B |